India has reached out to top American pharma companies seeking investment in the country’s pharmaceutical and medical devices sector, which gains urgency in view of a devastating second wave of the coronavirus pandemic. India’s Ambassador to the US Taranjit Singh Sandhu has held virtual meetings with Alberta Bourla, the CEO of Pfizer, Thermo Fisher CEO Marc Casper, Bernd Brust, the chairman and CEO of Antylia Scientific, and Joseph Repp, the CEO of Pall Life Sciences.
He also had a call with Emmanuel Ligner, the CEO and president of Cytiva. During his interactions with the pharma companies, Sandhu mentioned that India is seeking to encourage investments into the pharmaceutical and medical devices sector.
India, he said, has recently launched a production linked incentive scheme that will provide the US companies new opportunities for investment. “Discussed ways in which Pfizer could support healthcare efforts, including vaccines in India, and strengthen our pandemic response,”…